Related by context. All words. (Click for frequent words.) 66 candidate bevirimat PA 65 melanocortin receptor agonists 65 antiinfectives called 64 fusion inhibitors 64 adrenergic regulation 63 novel therapeutic antibodies 63 SGLT Inhibitors 63 oral dihydropyrimidine dehydrogenase DPD 62 SPL# Gel vaginal microbicide 62 anticoagulant reversing agent 62 Inotek Pharmaceuticals Corporation 62 Crofelemer budesonide foam 62 NS5b 62 non nucleoside inhibitor 62 IMiDs ® 62 Ostabolin C TM 62 maturation inhibitor 61 adrenal steroid hormones 61 PI3K/Akt pathway inhibitor 61 oral ghrelin agonist 61 diabetes irritable bowel 61 4SC AG ISIN DE# 61 HCV polymerase 61 commercializing oxidized glutathione 61 selective androgen receptor modulators 61 delta opioid receptor 61 pharmacogenomic translational research 61 non nucleoside HCV 60 Atripla combines 60 BiTE antibodies represent 60 RNA antagonists 60 Ferring Pharmaceuticals privately 60 novel peptides 60 lipid nanoparticle 60 Entry Inhibitor 60 TKB# 60 humanized therapeutic 60 investigational integrase inhibitor 60 rxRNA 60 thiazolides 60 pralatrexate injection folate analogue 60 novel anti infective 60 commercialize apixaban 60 AKT inhibitor 60 ABL inhibitor 60 Merck OSI Pharmaceuticals 60 HIV integrase inhibitors 59 leveraging oligonucleotide 59 called lipopeptides 59 includes AstraZeneca Accolate 59 BioFocus DPI Galapagos 59 Alfacell proprietary ribonuclease 59 5 lipoxygenase activating 59 Inc. NASDAQ TRGT 59 receptor modulators 59 platform HDL Mimetic 59 Empatic ™ 59 Inc. www.micromet inc.com 59 cosmetic cosmeceutical products 59 PORxin TM platforms 59 oxazolidinone 59 catalytic antioxidant compounds 59 apricitabine ATC 59 HIV integrase inhibitor 59 GVAX ® 59 inhibitor PRO 59 investigational pan BCR 59 Belimumab 59 commercializing aptamer therapeutics 58 BLyS specific 58 transcriptase inhibitor NNRTI 58 molecular biology genomics proteomics 58 Aganocide 58 Cephalon GlaxoSmithKline 58 perifosine novel potentially 58 NuMimetic TM 58 personalized cellular immunotherapy 58 potently inhibit 58 oral nucleoside analogue 58 biodefense pathogens 58 small molecule thrombopoietin 58 cyclophilin inhibitors 58 histone deacetylase HDAC inhibitors 58 Kosan dependence 58 DNA methyltransferase inhibitors 58 optical biosensors 58 MSCRAMM ® 58 staphylococcal vaccine 58 MKC# MT 58 Eniluracil 58 Predictive medicine 58 candidate REP# 58 Nanobody R 57 ADCC enhanced 57 stage antibody MT# 57 hepatitis C lupus 57 RONDEL ™ 57 Integrase Inhibitor 57 IMiDs R 57 romazarit 57 selectively inhibit replication 57 R MSCRAMM 57 IMPDH inhibitor 57 tiapamil 57 Anticalins R 57 HTS assay 57 MTP inhibitor 57 lead Aganocide compound 57 Initiates Enrollment 57 Aganocide ® 57 non porcine pancreatic 57 recombinant biopharmaceutical 57 Pruvel TM 57 candidate deforolimus 57 GPR# agonist 57 Critical Therapeutics Zyflo 57 pan BCR ABL 57 Naglazyme R 57 selective adhesion molecule 57 Hedgehog pathway inhibitor 57 VEGFR2 inhibitor 57 candidate custirsen 57 Syncria albiglutide 57 class anticancer quinolone 57 Completes Patient Enrollment 57 CCR5 mAb 57 oral proteasome inhibitor 57 HIV maturation inhibition 57 Aurora kinase inhibitor 57 Budesonide foam crofelemer 57 Albuferon albinterferon alfa 2b 57 5 HT3 antagonist 57 Prodarsan R 57 Initiates Phase II 57 Nicotine Conjugate Vaccine 57 INxin TM 56 P#X# antagonist 56 Pharma Merck Serono 56 FOLOTYN ® 56 symbol AVXL 56 oncolytic virus therapies 56 MKC# MKC# PP 56 cancer indications bafetinib 56 DNA RNA Medicines 56 CCR5 antagonist 56 kidney urologic 56 RenaZorb TM 56 candidate ATHX 56 ATRA IV 56 asthma COPD Chronic 56 developing Zerenex ferric 56 HCV NS5B polymerase 56 include Altastaph TM 56 LentiVector technology 56 developing ACAPODENE 56 HCV RNA polymerase 56 Nanobodies ® novel 56 anti botulism antibody 56 novel peptide 56 IAP inhibitors 56 Vicriviroc 56 Pentad TM 56 small molecule glucokinase 56 triggers apoptosis programmed 56 XL# anticancer compounds 56 solid tumors ZYBRESTAT 56 Therapeutic Competitors Companies 56 proprietary PEGylation 56 orally administered inhibitor 56 product AMD# 56 HEPLISAV TM hepatitis B 56 Akebia Therapeutics 56 delta gamma agonist 56 Miraxion Amarin lead 56 INSPIRE Trial Phase III 56 topically applied SEPA 56 small molecule macrocyclic 56 MicuRx 56 AAG geldanamycin analog 56 Initiates Clinical Trial 56 therapeutic monoclonal antibodies 56 XmAb ® 56 NYSE Amex AEN 56 Genasense oblimersen sodium Injection 56 lipoglycopeptide 56 sodium glucose cotransporter 56 discovery affiliate Keddem 56 anionic backbone 56 small molecule Hedgehog 56 MEDA AB publ 56 sulfonylhydrazine class 56 molecular imaging radiopharmaceuticals 56 PNP inhibitor 56 inflammatory autoimmune diseases 56 therapeutic monoclonal antibody 56 HCV polymerase inhibitors 56 Genentech sanofi aventis 56 autologous cellular immunotherapies 56 human IgG1 monoclonal 56 SinuNase ™ 56 NNR Therapeutics selectively modulate 56 platinum chemotherapeutic 56 candidates Azedra TM 55 markets Testim ® 55 5 HT2A inverse 55 Personalized Immunotherapy 55 Luveris R Ovidrel R 55 BiTE R 55 HuCNS SC ® 55 nitric oxide donating 55 eighth Mersenne prime 55 Quinamed R 55 novel immunomodulatory 55 CCR5 receptor antagonist 55 recombinant subunit vaccine 55 By JAMAAL ABDUL 55 synthetic cannabinoid compounds 55 please visit http:/www.vandapharma.com 55 polymerase inhibitor 55 histone deacetylase HDAC 55 molecular chaperone regulation 55 Silodosin 55 accumulate preferentially 55 activate SIRT1 55 anti CD3 monoclonal 55 AIDSVAX contains 55 improve impulse conduction 55 Carigent 55 novel immunotherapies 55 using ImmunoGen TAP 55 microRNA antagonists 55 HCV NS3 protease 55 SIX RO ROG 55 novel emulsion formulation 55 Provectus Pharmaceuticals specializes 55 molecular therapeutics immunotherapies 55 bendamustine ifosfamide 55 BY WILLA J. 55 oral renin inhibitor 55 Oracea TM 55 IAP inhibitor 55 Nitazoxanide 55 ALN PCS 55 developing TB4 55 PDE4 inhibitor 55 PORxin TM 55 Through Glycoscience R 55 gastro intestinal inflammation 55 peripherally acting 55 anti secretory 55 Selective Electrochemical Tumor Ablation 55 thrombin component 55 Erimos 55 Faithfully Fit exercise 55 please visit http:/www.sunesis.com 55 PDE# 55 DiLA2 55 commercialize CorMedix drug 55 Pruvel ™ 55 semi synthetic lipoglycopeptide 55 Lenocta TM sodium stibogluconate 55 Stapled Peptide 55 virosome 55 DG# compounds targeting 55 biopreservation media products 55 NASDAQ CGEN announced 55 Omacetaxine 55 regenerative therapeutics 55 Peptelligence ™ platform 55 neuro inflammatory disorders 55 TRIOLEX ™ 55 MVA HPV IL2 55 ARRY # 55 world safest multivalent 55 intranasal formulation 55 Veronate R 55 protein kinase inhibitors 55 MKC# 55 taxane derivative 55 midstage clinical 55 epothilones 55 Presents Preclinical Data 55 metaglidasen 55 immunotherapeutic agent 55 ImQuest 55 Enanta Pharmaceuticals 55 rotavirus shingles 55 cladribine Cladribine Tablets 55 Elvitegravir 55 topical antifungal product 55 development peramivir neuraminidase 55 LNP formulations 55 Maribavir 54 Senexis 54 RAF kinase 54 leading oral taxane 54 promising anticancer 54 glucose metabolic disorders 54 serious systemic Staphylococcal 54 neuro inflammatory 54 HepDirect prodrug 54 active AKT inhibitor 54 Initiates Clinical 54 HepeX B TM 54 dimebon latrepirdine 54 drug pipeline TAFA# 54 affiliate Evogene Ltd. TASE 54 RTP #i 54 HCV protease inhibitors 54 non thiazolidinedione TZD 54 Inc. Nasdaq IMGN 54 telomerase therapeutic 54 chimeric monoclonal antibody 54 Presents Positive 54 Selzentry maraviroc 54 Visit www.BASInc.com 54 Telik logo TELINTRA 54 selectin antagonist 54 oral Janus kinase 54 Tesetaxel 54 topical gel formulation 54 IMPACS R 54 Panacos proprietary 54 fusion enhancers 54 NU# direct 54 Investigational Oral 54 compound CMX# 54 XOMA 3AB 54 gets USFDA nod 54 include VALSTAR TM 54 liposomal delivery 54 Submits NDA 54 immunotherapeutic vaccine 54 Zoraxel TM 54 Merck Serono Nycomed 54 2 methoxyestradiol 54 oral immunomodulatory 54 selective estrogen receptor modulator 54 Presents Preclinical 54 developing adecatumumab 54 JAK2 Inhibitor 54 sapacitabine CYC# 54 commercialize OncoGenex lead 54 AVAX AC Vaccine 54 Integrase inhibitors 54 novel RNAi therapeutics 54 novel L DOS# 54 TLR7 agonist 54 pan histone deacetylase 54 albiglutide 54 ddRNAi 54 skeletal sarcomere activators 54 Rigel R# 54 adecatumumab MT# 54 Tarvacin TM 54 TM Aganocide 54 initiated Phase Ib 54 GRNOPC1 contains 54 targeted immunotherapies 54 neuronal nicotinic receptor NNR 54 International LAB Pharma 54 adenosine A2A 54 product candidate Lpathomab 54 Nanomedicine Nanomedicine 54 defensin mimetic antibiotic 54 novel antiviral therapeutics 54 secretory phospholipase A2 54 LymphoStat B belimumab 54 Launches Generic Version 54 TKM Ebola 54 cytidine nucleoside analog 54 TELINTRA R 54 HCV protease inhibitor 54 AN# novel 54 superparamagnetic iron oxide nanoparticles 54 generation URAT1 inhibitor 54 phase III isavuconazole 54 developing Zerenex TM 54 novel histone deacetylase 54 biased ligand 54 Reports Preclinical Data 54 Anidulafungin 54 Bayer HealthCare Onyx Pharmaceuticals 54 HDL Mimetic Peptide 54 cathepsin K inhibitor 54 novel VDA molecule 54 Cobalamin TM mediated 54 Panzem R 54 Cariprazine 54 ImmunoGen TAP technology 54 ZFP Therapeutics 54 GRNVAC1 54 delivers fluocinolone acetonide FA 54 lipopeptide 53 CryoStor TM platform 53 TRACON Pharmaceuticals 53 antisense drug 53 beta secretase inhibitors 53 CCR9 antagonist 53 Begins Dosing 53 lead molecular radiotherapeutic 53 programs visit http:/www.bionovo.com 53 evaluating satraplatin 53 recombinant PSMA vaccine 53 selectively modulate 53 Diep Tran MD 53 ART# 53 ADP receptor antagonist 53 Elesclomol 53 3TC lamivudine 53 AVEO integrates proprietary 53 Company AMEX SNT 53 candidate DB# 53 hepatitis C polymerase inhibitor 53 IMiDs ® compound 53 enhanced skin permeation 53 hyaluronidase enzyme 53 Arno Therapeutics 53 engineered proteases 53 Hsp# Inhibitor 53 please visit http:/www.atherogenics.com 53 Bremelanotide 53 Additionally Soligenix 53 oncology infectious diseases 53 visit http:/www.amgen.com 53 VentiRx Pharmaceuticals 53 anticancer therapeutics 53 Intermezzo ® zolpidem tartrate 53 co receptor CCR5 53 hepatitis B immune globulin 53 R#/MEM # 53 Solazed TM 53 renin inhibitors 53 humanized monoclonal 53 selectively inhibit 53 itraconazole Sporanox 53 memantine HCl 53 carbapenem 53 novel topoisomerase 53 Locked Nucleic Acid LNA 53 PNT# 53 proprietary BiTE R 53 siRNA therapeutics 53 inflammation metabolic disorders 53 regenerative medicine transplantation 53 THR beta agonist 53 ZyStor Therapeutics Inc. 53 immunotherapeutics 53 vapreotide acetate 53 highly selective inhibitor 53 HCV nucleotide polymerase inhibitor 53 Biomoda www.biomoda.com 53 nilotinib Tasigna ® 53 EHT AGN 53 Romidepsin 53 Ostarine ™ 53 virus HCV protease inhibitor 53 Percocet Oxycontin Vicodin 53 investigational oral hepatitis C 53 Janus Kinase 53 targeted radiotherapeutic 53 Daclizumab 53 soft tabs levitra 53 HepDirect R 53 Protexia ® 53 Systemic Delivery 53 including eniluracil ADH 53 CYT# potent vascular disrupting 53 deCODE chemistry 53 RNA therapeutics 53 IV meropenem 53 AVEO Pharmaceuticals NASDAQ 53 EVIZON TM squalamine lactate 53 treat nicotine addiction 53 anti miRs antisense oligonucleotide 53 humanised monoclonal antibody 53 ALTROPANE R 53 Antonio Deberry 53 nucleotide analog 53 SuperAntibody 53 include PLX IBD 53 resorbable biomaterials 53 MT#/MEDI-# 53 Pharmos proprietary 53 generation NEUGENE antisense 53 personalized dendritic cell 53 AAG KOS 53 XL# XL# 53 Shigatoxin producing E. coli 53 CD# CEA 53 Mg Uk 53 dipeptidyl peptidase IV 53 integrase inhibitors 53 HGS ETR1 mapatumumab 53 folate analogue metabolic 53 Sapacitabine 53 Lixivaptan 53 CYP#A# isoenzyme 53 novel orally administered 53 developing ostarine selective 53 MEK Inhibitor 53 oral antiviral 53 Aeolus Pharmaceuticals Announces 53 reversible inhibitors 53 biobetter 53 MEK inhibitor 53 Fc fusion protein 53 candidate CRLX# 53 candidate XP# 53 maturation inhibitors 53 nucleoside analog 53 demethylation agents 53 OTCBB NRGX 53 Locked Nucleic Acid 53 theranostic 53 lupus hepatitis C 53 LymphoStat B TM 53 Cyclooxygenase Inhibiting Nitric Oxide 53 prophylactic vaccine 52 immunology genetics 52 please visit www.advaxis.com 52 Thiovir 52 trastuzumab DM1 T DM1 52 specific chemokine receptors 52 dihydrofolate reductase DHFR 52 peptidic compound 52 Immune SIMULATORS 52 Synageva BioPharma Corp. 52 SCIB1 52 Viagra Soft Cialis Soft 52 chemistry microbiology immunology 52 proteasome inhibitor 52 5 HT2A serotonin 52 multicenter Phase III 52 HuCAL PLATINUM ® CysDisplay 52 treats acute lymphoblastic 52 specific neuronal nicotinic 52 BRAF kinase 52 mild vasodilator 52 Brussels THR 52 oral Hsp# inhibitor 52 MAGE A3 ASCI 52 TRIOLEX HE# APOPTONE HE# 52 DEB# 52 development DSC# novel 52 visit www.targanta.com 52 oral talactoferrin 52 Antibody Drug Conjugate 52 coupled receptor GPCR 52 Epothilones 52 XL# XL# XL# XL# 52 ZFNs clinical trials 52 Tekmira SNALP stable 52 product platforms GVAX 52 forodesine hydrochloride 52 small molecule VR1 52 agonistic human 52 antiviral therapeutics 52 ThermoDox ® clinical 52 virology immunology 52 IMiDs 52 compound INCB# 52 potent recombinant 52 investigational humanized monoclonal antibody 52 MVA BN R 52 proprietary BiTE ® 52 Aurora Kinase 52 treat refractory angina 52 MCSP respectively 52 Aganocide R 52 ALN TTR 52 IL-#/# 52 lipopeptides 52 Mipomersen 52 Inc. Nasdaq OXGN 52 multivalency 52 Lisofylline LSF 52 Annamycin 52 Vaccinex 52 HuMax TAC 52 oxidative stress inducer 52 NRTIs NNRTIs 52 oral ferric iron 52 Tofacitinib 52 activin receptor type 52 Phase #/#a 52 Monoclonal antibody 52 Cyclosert TM 52 non peptidic protease 52 IgG1 monoclonal antibody 52 Deforolimus 52 GeneGo develops systems 52 toenail onychomycosis 52 novel orally bioavailable 52 reverse transcriptase inhibitors 52 Adnectin 52 AQD class 52 RiVax 52 R sorafenib tablets 52 peptibody 52 orally bioavailable 52 INS# [001] 52 TBC# 52 EOquin TM phase 52 Ovitrelle R Serostim 52 Zalypsis 52 hepatitis C protease inhibitor 52 oral prodrug 52 Pfizer Selzentry 52 Piperacillin 52 integrase inhibitor 52 dermaceuticals 52 naloxol derivative 52 protein tyrosine phosphatase 1B 52 POTELLIGENT R 52 BHT DNA 52 Tykerb lapatinib 52 nucleotide polymerase inhibitor 52 commercializing novel biotherapeutics 52 TRANSDUR ® 52 investigational protease inhibitor 52 highly selective endothelin 52 reverse transcriptase inhibitor 52 mda 7 52 visit www.sciclone.com 52 anti PlGF 52 ATL# [001] 52 Aptamer 51 MediVas 51 renin inhibitor 51 Biopharmaceuticals AG 51 epothilone 51 microbiologist Taha 51 NTDDS 51 TKM PLK1 51 Peixuan Guo 51 Samjin 51 selective immunoproteasome inhibitor 51 Proellex TM 51 potent topoisomerase II 51 SGLT inhibitors 51 DGAT 51 generation antisense 51 gallium containing 51 Sphingomab TM 51 ELND# AZD 51 systemic RNAi therapeutic 51 hormone LHRH antagonist 51 drug conjugate ADC 51 Imatinib mesylate 51 vaginal microbicide gel 51 lamivudine zidovudine 51 tenofovir disoproxil fumarate Viread 51 Tarmogen 51 http:/www.sangamo.com 51 Homspera TM 51 receptor inhibiting monoclonal 51 Phase III ADT 51 Curaxin CBLC# 51 technology visit http:/www.genmab.com 51 Arcelis ™ 51 polymer conjugate technology 51 intravesical infusion therapy 51 Pharmos pipeline 51 Xcytrin R 51 Nutra Pharma wholly owned 51 cortisol synthesis 51 dasatinib Sprycel ® 51 compound PMX # 51 PEGylated docetaxel 51 histone deacetylase inhibitors 51 visit www.genmab.com 51 Lenocta 51 3 registrational trial 51 VBL proprietary 51 estrogen receptor beta agonist 51 anti tubercular 51 SparVax ™ 51 peptide therapeutics 51 Phase 2b Trial 51 Lixisenatide 51 hepatoprotective agent 51 M# rationally 51 mertansine 51 cardio metabolic diseases 51 bioprocess engineering 51 NS5B polymerase 51 M2 subunit 51 multitargeted 51 ketolide antibiotic 51 PrevOnco 51 DOS# 51 NASDAQ ARRY 51 selective orally bioavailable 51 intranasal insulin product 51 markets COLAZAL 51 fusion inhibitor 51 CCR5 receptor antagonists 51 AdVac ® 51 oral Factor Xa 51 Sodium Sulfate Sodium Chloride 51 prostanoid 51 platforms GVAX 51 Nasdaq PGNX today 51 www.cellgenesys.com 51 targeting miR 51 CYP#A# CYP#D# 51 microfluidics microelectromechanical systems 51 immunotherapeutic approaches 51 oncology metabolic disorders 51 IMiD 51 antimitotic 51 selective serotonin 2C receptor 51 acadesine 51 SAR# [002] 51 emtricitabine FTC 51 class oral heparinoid 51 Endotis 51 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 51 humanized monoclonal antibody 51 next generation URAT1 51 REGN# 51 Plasma Converter TM 51 nucleoside tide 51 Cobalamin TM 51 Nasdaq IDRA today 51 delivered RNAi therapeutic 51 zolpidem tartrate sublingual tablet 51 Ltd Giza Pitango 51 BCR ABL inhibitors 51 CK # novel 51 immunotoxin 51 Maraviroc 51 pharmaceuticals nutritionals 51 Dr. Aiping Young 51 Archexin 51 Receives Fast Track 51 seliciclib CYC# 51 SARMs 51 Anat Cohen Dayag 51 acetonide FA 51 rxRNA TM compounds 51 applied vaginally 51 NovaBay Aganocide 51 signal transduction inhibitor 51 advanced polymer conjugate 51 Inc. www.chemaphor.com uses 51 reformulates existing FDA 51 PSN# [002] 51 purinergic receptors P#X# 51 siRNA binds 51 Hematide ™ 51 miconazole Lauriad ® 51 VitiGam 51 eligen 51 INFeD R 51 small molecule defensin 51 DURECT proprietary 51 CCR5 inhibitor 51 agents Tabun Sarin 51 omecamtiv mecarbil formerly 51 apoptosis inducer 51 pan HDAC inhibitor 51 PKC# 51 DuPont http:/www.dupont.com 51 KL4 Surfactant 51 apoptosis inducers 51 TRAIL receptor antibodies 51 pharmaceuticals biopharmaceuticals 51 cyclin dependent kinase inhibitor 51 Squalamine 51 ALN HPN 51 Prodarsan ® 51 Sudhir Agrawal D.Phil 50 CDK cyclin dependent 50 virus AAV 50 5 HT4 50 Phase 2b Clinical Trial 50 DPX Survivac 50 triciribine phosphate monohydrate 50 polysaccharide polymer 50 resolvin 50 generation radiolabeled antibody 50 AKIP ™ 50 SMIP 50 oral NKTR 50 preclinical compounds 50 Muraglitazar 50 mRNA antagonist 50 ALN HTT 50 phases IIb 50 Nventa proprietary CoVal 50 bioinnovation 50 Oragens R 50 XmAb 50 Tarvacin Anti Cancer 50 Elagolix 50 Delafloxacin 50 Aviptadil 50 TLR Therapeutics 50 Eligen ® Technology 50 vinca alkaloid 50 IPL# 50 demonstrated antitumor activity 50 lucinactant 50 tyrosine kinase inhibitor TKI 50 oncolytic 50 Tropical Diseases NITD 50 arsenic trioxide injection 50 nelfinavir Viracept 50 drug Isentress 50 generation Hsp# inhibitor 50 JAK1 50 progressive metastatic prostate 50 PHX# 50 liposomal formulation 50 Nanobody 50 clinical trials Archexin ® 50 Aurexis 50 selective androgen receptor modulator 50 whereby bioactive signaling 50 novel antimitotic agent 50 oncolytic vaccine 50 Amigal TM 50 nucleotide analogue 50 dSLIM 50 Dyax phage display 50 clinical trials Archexin 50 Aflibercept VEGF Trap 50 evaluating tivozanib 50 radezolid 50 BMS # 50 Hematide TM 50 Oxytrex TM 50 inhibits Akt activation 50 Temsirolimus 50 forodesine 50 DGAT1 inhibitors 50 CCR5 antagonists 50 antiangiogenesis therapies 50 hypoxia selective 50 Supernus Pharmaceuticals 50 molecular imaging radiopharmaceutical 50 About Biovitrum Biovitrum 50 POTELLIGENT ® Technology 50 dermatology urology 50 Crucell genetically engineered 50 dendrimer nanotechnology 50 inhibit oxidative stress 50 certain protein tyrosine 50 PSMA ADC 50 TAFA# 50 Polymerase Inhibitor 50 p# inhibitor 50 biologic therapeutics 50 UVIDEM 50 chemically modified siRNA 50 Transfersome ® 50 nanopharmaceutical 50 ENMD # 50 vinorelbine tartrate 50 histone methyltransferases HMTs 50 Nanobodies 50 multi kinase inhibitor 50 polymerase inhibitors 50 reversible inhibitor 50 orally inhaled migraine 50 Affibody 50 REVIVE Diabetes 50 Eg5 kinesin motor 50 penetrating peptides 50 Onalta 50 neuronal nicotinic receptors NNRs 50 inhibit replication 50 sorafenib tablets 50 humanized monoclonal antibodies 50 alpha glucans 50 Kahalalide F 50 ospemifene 50 Junovan TM 50 Antigen Express website 50 DepoVax ™ 50 immuno modulatory 50 antitumoral 50 RNAi therapeutic platform 50 CFTR corrector 50 elotuzumab 50 thiazolidinedione TZD 50 SNS# T 50 Talabostat 50 Etravirine 50 Angiocept 50 MEK inhibitors 50 IMC #B 50 Jubilant Biosys 50 CCX# 50 Kinase Inhibitor 50 plasmid DNA pDNA 50 agonists antagonists 50 tubulin inhibitors 50 HCV nucleoside polymerase inhibitors 50 targeted antifolate 50 lexidronam injection 50 Elusys 50 isoform selective 50 Imec performs world 50 vivo toxicology 50 dinosaurs Yokoyama 50 Fleximer R 50 novel synthetic peptide 50 ERYtech 50 gastrin analogue TT 50 GLP toxicology studies 50 endothelin receptor antagonists 50 Iluvien ® 50 treat lupus renal 50 MT# MEDI 50 sodium glucose transporter 50 Ceflatonin R 50 please visit www.metabolon.com 50 ATL# [002] 50 RNAi Therapeutic 50 HQK 50 www.holliseden.com 50 therapeutic peptide 50 PEGylated interferon 50 mitogen activated ERK kinase 50 HER pathway 49 histone deacetylase HDAC inhibitor 49 targeting PCSK9 49 molecular biology genomics 49 OMP #M# 49 RONDEL TM 49 Trastuzumab DM1 49 essential thrombocythemia ET 49 pharmacology physiology 49 Guanilib 49 Ozarelix 49 Isis antisense 49 KSP inhibitor 49 signal detection CTSD 49 protein receptors lectins 49 genetics immunology 49 bio therapeutics 49 proteomics metabolomics 49 receptor tyrosine kinase inhibitor 49 gamma secretase activating 49 OTCBB NRGX biotechnology 49 Zoraxel 49 oncology endocrinology 49 GATTEX ™ 49 CD# antibody [002] 49 trastuzumab Herceptin R 49 compound perifosine 49 beta 1a 49 CTA# Injection 49 CD4 monoclonal antibody 49 small molecule tyrosine 49 parenteral administered 49 Nasdaq DVAX 49 BEMA ® 49 JAK inhibitors 49 malignant mesothelioma Alfacell 49 compound ITMN 49 GW# [003] 49 sodium Injection 49 gamma secretase inhibitor 49 PTH analogue 49 Nasdaq PARD 49 Protein Kinase C 49 HEPLISAV ™ 49 system REG1 consists 49 investigational hepatitis C 49 recurrent metastatic ovarian cancer 49 PRTX 49 ALN TTR# 49 targeting CD# 49 erlotinib Tarceva R 49 oncology immunology 49 Georges Gemayel 49 immune stimulatory 49 Enkephalin 49 transthyretin TTR 49 prokinetic agent 49 imatinib Gleevec ® 49 oral picoplatin 49 conducting reconfirmation 49 oral transmucosal 49 Zenvia ™ 49 drug conjugate 49 Inc. NASDAQ GLGC 49 reagents kits 49 systemic sclerosis SSc 49 KuDOS 49 RAS MAPK pathway 49 Jonathan Leor 49 ricin toxin botulinum toxin 49 immune modulators 49 palifosfamide Zymafos TM